Rare diseases
Investigational molecules
Locations
Study of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
NorwayStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
NorwayStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
NorwayStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
NorwayPhase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)
NorwayEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
NorwayA double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis
NorwayPhase II study of intratumoral getacatetide in patients with locally advanced or metastatic adrenocortical carcinoma
NorwayTicagrelor, Acetylsalicylic Acid and Prasugrel in Patients with Acute Coronary Syndrome: A Study of Antiplatelet Management
NorwayA Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety
NorwayZodasiran for Adolescents With Homozygous Familial Hypercholesterolemia: A Phase 3 Study of Efficacy and Safety
NorwayEfficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial
NorwayTell us about your condition – we search every trial in Europe and connect you with the right site.
